145 related articles for article (PubMed ID: 26536348)
21. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
22. [ATM gene mutations in Chinese patients with ataxia telangiectasia].
Jiang H; Tang B; Hu Z; Xia K; Xu B; Tang J; Shen L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):121-4. PubMed ID: 15793768
[TBL] [Abstract][Full Text] [Related]
23. STK10 missense mutations associated with anti-apoptotic function.
Fukumura K; Yamashita Y; Kawazu M; Sai E; Fujiwara S; Nakamura N; Takeuchi K; Ando M; Miyazono K; Ueno T; Ozawa K; Mano H
Oncol Rep; 2013 Oct; 30(4):1542-8. PubMed ID: 23842845
[TBL] [Abstract][Full Text] [Related]
24. STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas.
Yoshida N; Tsuzuki S; Karube K; Takahara T; Suguro M; Miyoshi H; Nishikori M; Shimoyama M; Tsukasaki K; Ohshima K; Seto M
Cancer Sci; 2015 Oct; 106(10):1455-62. PubMed ID: 26176172
[TBL] [Abstract][Full Text] [Related]
25. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia.
Birrell GW; Kneebone K; Nefedov M; Nefedova E; Jartsev MN; Mitsui M; Gatti RA; Lavin MF
Hum Mutat; 2005 Jun; 25(6):593. PubMed ID: 15880721
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
27. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
28. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
29. Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.
Winrow CJ; Pankratz DG; Vibat CR; Bowen TJ; Callahan MA; Warren AJ; Hilbush BS; Wynshaw-Boris A; Hasel KW; Weaver Z; Lockhart DJ; Barlow C
Hum Mol Genet; 2005 Sep; 14(18):2671-84. PubMed ID: 16087685
[TBL] [Abstract][Full Text] [Related]
30. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.
Fujiwara SI; Yamashita Y; Nakamura N; Choi YL; Ueno T; Watanabe H; Kurashina K; Soda M; Enomoto M; Hatanaka H; Takada S; Abe M; Ozawa K; Mano H
Leukemia; 2008 Oct; 22(10):1891-8. PubMed ID: 18633432
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase.
Lai WL; Hung WY; Ching YP
Oncogene; 2014 Nov; 33(45):5303-9. PubMed ID: 24240686
[TBL] [Abstract][Full Text] [Related]
32. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.
Tan BT; Warnke RA; Arber DA
J Mol Diagn; 2006 Sep; 8(4):466-75; quiz 527. PubMed ID: 16931587
[TBL] [Abstract][Full Text] [Related]
33. [Research on clinical characteristics and ATM gene mutations in Chinese patients with ataxia-telangiectasia].
Jiang H; Tang BS; Hu ZM; Xia K; Xu B; Tang JG
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1117-20. PubMed ID: 16029571
[TBL] [Abstract][Full Text] [Related]
34. STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.
Simpson HM; Furusawa A; Sadashivaiah K; Civin CI; Banerjee A
Oncotarget; 2018 Mar; 9(24):16792-16806. PubMed ID: 29682185
[TBL] [Abstract][Full Text] [Related]
35. Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.
Liu X; Ning J; Liu X; Chan WCJ
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954378
[TBL] [Abstract][Full Text] [Related]
36. Computational Analysis of Non-synonymous SNPs in ATM Kinase: Structural Insights, Functional Implications, and Inhibitor Discovery.
Panchal NK; Samdani P; Sengupta T; Prince SE
Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38489015
[TBL] [Abstract][Full Text] [Related]
37. Mutations of epigenetic genes and correlation with treatment response in peripheral T-cell lymphoma.
Wei C; Wang W; Li W; Zhang Y; Zhao D; Zhang W; Zhou D
Clin Transl Med; 2024 Jan; 14(1):e1491. PubMed ID: 38239088
[No Abstract] [Full Text] [Related]
38. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
[TBL] [Abstract][Full Text] [Related]
39. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
40. Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma.
Nielsen JS; Chang AR; Wick DA; Sedgwick CG; Zong Z; Mungall AJ; Martin SD; Kinloch NN; Ott-Langer S; Brumme ZL; Treon SP; Connors JM; Gascoyne RD; Webb JR; Berry BR; Morin RD; Macpherson N; Nelson BH
Oncoimmunology; 2017; 6(7):e1321184. PubMed ID: 28811957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
